Dietary Tryptophan Allocation in Depression: Serotonin–Kynurenine Balance, Microbial Indole Pathways, and Inflammatory Phenotypes
Nutrients · 2026
DOI: 10.3390/nu18162716 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Bernard Kordas. Beteiligte Einrichtung: Department of Human Physiology and Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-082 Olsztyn, Poland. Hauptthemen laut MEDLINE: Tryptophan, Kynurenine, Serotonin, Depression. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, Poland, Minister of Science.
Themen: Depression
Abstract (Originalsprache)
Depression is defined by clinical symptoms, but its biology varies considerably among patients. In this review, dietary tryptophan allocation describes the routes taken by tryptophan after intestinal absorption. Some is incorporated into proteins. Some enters serotonin and melatonin synthesis or the kynurenine pathway, while gut bacteria convert another fraction into indole compounds. Brain availability also depends on the circulating free pool and competition with other large neutral amino acids. This term does not imply a new biochemical pathway. It allows these known processes to be considered in relation to inflammation, metabolism, the gut microbiota, medication use, and current disease state. Recent meta-analyses indicate that peripheral tryptophan is lower in depression. They do not show a consistent increase in the kynurenine-to-tryptophan ratio, and findings from cerebrospinal fluid vary between studies. Human multiomics studies have associated microbial and metabolite profiles with cognition and response to treatment, although the evidence remains largely correlational. Changes in kynurenine, 3-hydroxykynurenine, and quinolinic acid are more apparent in inflammatory subgroups than in unselected samples. Modern evidence for L-tryptophan monotherapy is sparse. Trials of 5-hydroxytryptophan and interventions directed at the gut microbiota have also produced mixed results. Studies should characterize participants and sampling conditions more carefully. Diet and competition among amino acids need to be recorded. Albumin concentration, medication exposure, and disease state also affect interpretation. Considering these variables together may improve biomarker analyses and support trials in more biologically homogeneous groups. Dietary tryptophan allocation is proposed for these research purposes, not for clinical diagnosis or routine supplementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Physiology and Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-082 Olsztyn, Poland.
ORCID-Profile: Bernard Kordas
Förderung
- National Science Centre, Poland
- Minister of Science
Zitieren
APA
Kordas, B. (2026). Dietary Tryptophan Allocation in Depression: Serotonin–Kynurenine Balance, Microbial Indole Pathways, and Inflammatory Phenotypes. Nutrients. https://doi.org/10.3390/nu18162716
Vancouver
Kordas B. Dietary Tryptophan Allocation in Depression: Serotonin–Kynurenine Balance, Microbial Indole Pathways, and Inflammatory Phenotypes. Nutrients. 2026. doi:10.3390/nu18162716
BibTeX
@article{Kordas2026,
author = {Kordas, Bernard},
title = {Dietary Tryptophan Allocation in Depression: Serotonin–Kynurenine Balance, Microbial Indole Pathways, and Inflammatory Phenotypes},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18162716}
}
EUVIMED